Variant report
Variant | esv3437082 |
---|---|
Chromosome Location | chr2:78639835-78640414 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | STAT3 | chr2:78640164-78640401 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:78637554..78639977-chr2:78766787..78768860,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-LRRTM4-3 | chr2:78639673-78640302 | NONHSAT071846 |
2 | lnc-LRRTM4-3 | chr2:78639919-78640220 | NONHSAT071847 |
3 | lnc-LRRTM4-3 | chr2:78637204-78640302 | NONHSAT071835 |
No data |
No data |
Variant related genes | Relation type |
---|---|
CYCSP6 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546051842 | chr2:78639835-78639836 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs569471264 | chr2:78639839-78639840 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs538461476 | chr2:78639872-78639873 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs558597979 | chr2:78640000-78640001 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs35046502 | chr2:78640046-78640047 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs566067342 | chr2:78640050-78640051 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs2018108 | chr2:78640076-78640077 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs554704166 | chr2:78640106-78640107 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs575072146 | chr2:78640201-78640202 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs576972841 | chr2:78640202-78640203 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs183564601 | chr2:78640211-78640212 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs557699685 | chr2:78640226-78640227 | Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs577481067 | chr2:78640230-78640231 | Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs6725336 | chr2:78640246-78640247 | Weak transcription | TF binding regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs564952541 | chr2:78640250-78640251 | Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs201153138 | chr2:78640284-78640285 | Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs386647656 | chr2:78640293-78640294 | Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs768071 | chr2:78640294-78640295 | Weak transcription | TF binding regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs532428946 | chr2:78640295-78640296 | Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs560769698 | chr2:78640296-78640297 | Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs114272335 | chr2:78640360-78640361 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs188844502 | chr2:78640364-78640365 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 18438408 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Epilepsy | 22083797 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:78634000-78643200 | Weak transcription | K562 | blood |
2 | chr2:78634200-78643600 | Weak transcription | HepG2 | liver |
3 | chr2:78640000-78640200 | Bivalent Enhancer | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr2:78640000-78640200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |